Findings from studies in chimeric mice suggest that the LPS-TLR4 pathway promotes HCC mainly by increasing proliferative and antiapoptotic signals in resident hepatocytes of non-myeloid origin (Dapito et al., 2012). This evidence concerns the gene TLR4 and hepatocellular carcinoma.